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Abstract.  CP190, a protein of 1,096 amino acids from 
Drosophila melanogaster, oscillates in a cell cycle-spe- 
cific manner between the nucleus during interphase, 
and the centrosome during mitosis. To characterize the 
regions of CP190 responsible for its dynamic behavior, 
we injected rhodamine-labeled fusion proteins span- 
ning most of CP190 into early Drosophila embryos, 
where their localizations were characterized using time- 
lapse fluorescence confocal microscopy. A  single 
bipartite 19-amino acid nuclear localization signal was 
detected that causes nuclear localization. Robust cen- 
trosomal localization is conferred by a separate region 
of 124 amino acids; two adjacent, nonoverlapping fu- 
sion proteins containing distinct portions of this region 
show weaker centrosomal localization. Fusion proteins 
that contain both nuclear and centrosomal localization 
sequences oscillate between the nucleus and the cen- 
trosome in a manner identical to native CP190. Fusion 
proteins containing only the centrosome localization 
sequence are found at centrosomes throughout the cell 
cycle, suggesting that CP190 is actively recruited away 
from the centrosome by its movement into the nucleus 
during interphase. Both native and bacterially ex- 
pressed CP190 cosediment with microtubules in vitro. 
Tests with fusion proteins show that the domain re- 
sponsible for microtubule binding overlaps the domain 
required for centrosomal localization. CP60, a protein 
identified by its association with CP190, also localizes 
to centrosomes and to nuclei in a cell cycle-dependent 
manner. Experiments in which colchicine is used to de- 
polymerize microtubules in the early Drosophila em- 
bryo demonstrate that both CP190 and CP60 are able 
to attain and maintain their centrosomal localization in 
the absence of microtubules. 
C 
ENTROSOMES are the major microtubule organizing 
centers found in animal cells. Properties intrinsic 
to centrosomes include the capacity to duplicate as 
well as the ability to nucleate and organize microtubule ar- 
rays. These arrays, in turn, are essential for a variety of cel- 
lular  processes  including  cell  division  and  chromosome 
segregation, directed cell movement, and general cytoplas- 
mic organization (for reviews see Mazia, 1987; Vorobjev 
and  Nadezhdina,  1987;  Schatten,  1994;  Kellogg  et  al., 
1994).  Despite  their  importance  and  the  fact  that  they 
have been studied for over a century, centrosomes remain 
a  mystery. We still do not understand  how centrosomes 
nucleate microtubules, how they duplicate and separate, 
or how the changes in centrosome composition and struc- 
ture that accompany the transition from interphase to mi- 
tosis occur. 
Our knowledge of the centrosome is largely phenome- 
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nological. A molecular characterization of the centrosome 
has been elusive due to its small size and paucity, which 
make biochemical purification difficult, and to its involve- 
ment in very general organizational processes, which makes 
genetic approaches problematic. Nevertheless, progress is 
being made. A  number of centrosomal components have 
already been identified and their cDNAs cloned. Compo- 
nents of the spindle pole body, the centrosome equivalent 
in yeast and Aspergillus, have also been identified and clues 
to their function have been obtained from the analysis of 
mutants (for reviews on known centrosomal components 
see Kalt and Schliwa, 1993; Kimble and Kuriyama, 1992). 
We  identified  a  protein  originally  called  DMAP190 
(Drosophila microtubule associated protein of 190 kD) us- 
ing a combination of microtubule affinity chromatography 
and immunocytology in Drosophila embryos (Kellogg et 
al.,  1989).  DMAP190 is a microtubule-associated protein 
that is  recruited to centrosomes at the  onset of mitosis. 
DMAP190 was found to be identical to the antigen recog- 
nized by the  Bx63  antibody, which was  uncovered in  a 
bank of monoclonal antibodies made to Drosophila nuclei 
(Whitfield et al.,  1988; Frasch et al.,  1986). In agreement 
© The Rockefeller University Press, 0021-9525/95/12/1261/13  $2.00 
The Journal of Cell Biology, Volume 131, Number 5, December 1995 1261-1273  1261 with other workers in the field, we now call this protein 
CP190 (for centrosomal protein of 190 kD). 
CP190 has been cloned and sequenced (Whitfield et al., 
1995; GenBank/EMBL/DDBJ accession number Z50021); 
the sequence predicts a novel protein of 1,096 amino acids 
with an isoelectric point of 4.5 and a molecular weight of 
120 kD.  CP190 shares a low level of amino acid identity 
(<15%) over a  considerable portion of its length with a 
class of proteins including neurofilaments, myosin heavy 
chain,  and  MAP-2.  This  homology is  thought  to  result 
from the presence of extensive tracts of ~ helical structure 
that CP190 is predicted to contain. Although most of the 
proteins in this class possess coiled-coil structural motifs, 
CP190 does not contain the heptad repeats expected in a 
coiled-coil  structure.  Sequence  comparisons  have  also 
identified a cluster of four putative zinc fingers between 
amino acids 472 and 590, roughly in the middle of the pre- 
dicted  protein  (Whitfield  et  al.,  1995).  Native  CP190  is 
found in nuclei during interphase. At prophase, upon nu- 
clear envelope breakdown, CP190 rapidly accumulates at 
centrosomes where it remains throughout mitosis; begin- 
ning at telophase, CP190 is again imported into reforming 
nuclei (Frasch et al., 1986; Whitfield et al., 1988; Oegema, 
K., B. Alberts, J. W. Sedat, and W. S. Marshall, manuscript 
in preparation). 
Immunoaffinity  chromatography  using  columns  con- 
structed from anti-CP190 antibodies identified a group of 
proteins that interact with  CP190  (Kellogg et al.,  1992). 
One of these, CP60 (centrosomal protein of 60 kD)  has 
been cloned and sequenced (Kellogg et al.,  1995).  CP60 
exhibits behavior similar to CP190; CP60 is found in elu- 
ares from microtubule affinity columns and localizes to nu- 
clei and to centrosomes in a cell cycle-dependent manner 
(Kellogg et al., 1992, 1995). However, CP60 shares no sig- 
nificant  amino  acid  homology with  CP190  or  with  any 
other known proteins (Kellogg et al., 1995). 
Our objectives in this work are twofold: to determine 
how CP190 achieves its dynamic cell cycle-dependent pat- 
tern of centrosomal and nuclear localization and to gain 
insight into the function of CP190 and CP60 in the Dro- 
sophila embryo. These studies are a first step towards un- 
derstanding the cell cycle-dependent changes in structure 
and function that occur at centrosomes. In this work, we 
focus on the identification of regions of CP190 important 
for its dynamic localization pattern and on an examination 
of the mechanism by which CP190 and CP60 localize to 
centrosomes in vivo. 
Materials and Methods 
Expression and Purification of CPI90 Fusion Proteins 
Two  types  of fusion proteins  were  used  in  these  experiments: 6XHis 
tagged fusion proteins were made using the QIA express pQE9 vector 
(Stuber,  1990)  from  Qiagen  (Chatsworth,  CA)  and  fusions with  glu- 
tathione-S-transferase  (GST) 1 were  made  using the  pGEX-2T  vector 
(Smith, 1988) with a modified polylinker. An oligonucleotide was synthe- 
sized and ligated between the BamHI and EcoRI sites of pGEX-2T to cre- 
ate the final sequence GGATCCGGTACCAGATCTCGAGTCGACAA- 
1. Abbreviations used in this paper: FPLC, fast protein liquid chromatog- 
raphy; GST, glutathione-S-transferase; MAP, microtubule-associated pro- 
tein; NLS, nuclear localization signal. 
GCTI'GGAATTC.  The  new  polylinker  thus  contains  the  following 
restriction enzyme cutting sites in order: BamHI, KpnI, BglfI, Xhol, SalI, 
HindlfI, and EcoRl. To generate the fragments of the CP190 DNA se- 
quence that were cloned to produce fusion proteins, we performed nested 
PCR using a  cDNA library as the template (Brown and Kafatos, 1988; 
Sambrook et al., 1989)  and Vent DNA polymerase (New England Bio- 
labs, Beverly, MA). The primers for PCR were derived by reference to 
the CP190 cDNA sequence (Whitfield et al.,  1995)  and they contained 
BgllI and HindlII sites at their 5' ends. The PCR products were cloned 
into  either  the BamHI/HindlII  sites in the pQE9  vector or  the BgllI/ 
HindIII sites in the modified pGEX-2T vector. The 6XHis fusion proteins 
therefore begin with the sequence MRGSHHHHHHGS. Transformation 
was into Escherichia coli M15(pREP4) for pQE9-CP190 constructs or E. 
coli TG-1 for pGEX-2T-CP190 constructs. 
A Ni-NTA resin (Qiagen) was used to purify the 6XHis fusion proteins. 
Chromatography was carried out according to the manufacturer's specifi- 
cations with  some modifications. The extract  buffer was often  supple- 
mented with 2 M urea, since it significantly improves fusion protein solu- 
bility. Columns were eluted in 1-ml fractions in a  buffer containing 250 
mM imidazole (Sigma Chemical Co., St. Louis, MO). GST fusion proteins 
were purified as in (Smith, 1988) with some buffer modifications. Proteins 
were eluted in 50 mM Na phosphate, pH 8.0, 500 mM NaC1, 10 mM 2-mer- 
captoethanol,  5  mM reduced  glutathione (Sigma Chemical Co.).  Both 
6XHis and GST fusion proteins were further purified on a Superose 12 gel 
filtration column equilibrated into FPLC buffer (50 mM Na phosphate, 
pH 8.0, 250 mM NaC1,  1 mM 2-mercaptoethanol) using a fast protein liq- 
uid chromatography (FPLC) system (Pharmacia Fine Chemicals, Piscat- 
away, NJ). 
The 6XHis fusion protein concentrations were determined by measur- 
ing their OD2s0 in FPLC buffer using extinction coefficients calculated 
from their primary amino acid sequence (Gill and von Hippel, 1989). The 
GST fusion protein concentrations were determined relative to bovine se- 
rum albumin using the Bradford assay (Bradford, 1976). 
Expression and Purification of CP60 Full-length 
Fusion Protein 
Full-length 6XHis CP60 fusion protein was produced using the pREST 
vector from Invitrogen (San Diego, CA). Nested PCR was performed as 
above using primers from the CP60 cDNA sequence (Kellogg et al., 1995). 
The primers contained BgllI and HindIII sites at their 5'ends and the re- 
sulting fragment was cloned into pRSETB.  Transformation was into E. 
coli BL21(DE3)plysS. Purification was as above except that a Superose 6 
gel filtration column was used in place of the Superose 12 column. 
Fluorescent Labeling of  Fusion Proteins 
To label fusion proteins, 0.75  ~1 of 12.5  mg/ml tetramethyl-rhodamine- 
NHS ester (Molecular Probes, Eugene OR), dissolved in either N,N-dimeth- 
ylformamide or dimethylsulfoxide, was added to 75 ~1 of fusion protein 
(1-5 mg/ml) in FPLC buffer. The mixture was incubated on ice for 5 min, 
and 7.5 Ixl of 2 M potassium glutamate, pH 8.0 and 0.75 ixl of 0.5 M dithio- 
threitol were added to stop the reaction. To remove free rhodamine, each 
labeled fusion protein was then transferred into injection buffer using a 
small spin column of Bio-Gel P-6 resin that excluded the protein (Bio-Rad 
Laboratories,  Hercules,  CA).  The  injection  buffers  used were  50  mM 
Hepes, pH 7.6,  250 mM KCI for the 6XHis fusion proteins and 50 mM 
Hepes, pH 7.6, 100 mM KCI for the GST fusion proteins. The extent of la- 
beling was assayed by spectroscopy; if the protein was over or under la- 
beled  the  procedure  was  repeated  varying the  amount  of  rhodamine 
added. (Proteins were considered over labeled if the absorption peak at 
522 nm, due to rhodamine dimers, was equivalent to or higher than the ab- 
sorption at 556 nm). Labeling stoichiometries were determined using a 
value of 50,000 M -1 cm  -1 for tetramethyl rhodamine (Molecular Probes, 
Eugene, OR) and were generally between 0.15 and 0.5 rhodamine/protein 
monomer. 
Embryo Injection and Confocal Microscopy 
Embryos were manually dechorionated and injected at 50% egg length ac- 
cording to standard procedures (Santamaria, 1986). The concentrations of 
the injected labeled fusion proteins were between 2 and 15 mg/ml, and the 
volume injected was approximately 1-2%  of the embryo's total volume 
(Foe and Alberts, 1983).  When added as a second marker, 40,000-mol wt 
fluorescein dextran (Molecular Probes, Eugene, OR) was injected at con- 
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was performed using a Nikon Optiphot fluorescence microscope equipped 
with the Bio-Rad MRC 600 laser scanning confocal attachment. All im- 
ages were collected using a Nikon 60× Plan Apo lens with a numerical ap- 
erture of 1.4. Embryo injection and screening was performed on a Nikon 
Diaphot inverted microscope equipped with an epifluorescence attach- 
ment. 
Fixation and Immunofluorescence 
Embryos  were  fixed  in  37%  formaldehyde  as  described  (Theurkauf, 
1992).  Vitelline  membranes were  removed with  methanol.  The  rabbit 
anti-CP60 antibody used has been described (Kellogg et al., 1995). The 
rabbit anti-CP190  antibody used was prepared by immunizing a rabbit 
with a total of 1.5 mg of a 6XHis fusion with CP190 amino acids 385-508, 
prepared as described above. Immunizations and bleeds were carried out 
by  the Berkeley Antibody Company (Richmond, CA). The  antibodies 
were affinity purified on a column of immobilized 6XHis CP190 amino ac- 
ids 385-508, prepared as described (Kellogg and Alberts, 1992) according 
to standard techniques (Harlow and Lane, 1988). Donkey Cy5 anti-rabbit 
and fluorescein anti-mouse antibodies were obtained from Jackson Im- 
munoResearch Laboratories, Inc. (West Grove, PA). 
Bead Cosedimentation Assays (Native CP190) 
Antibodies were coupled to Affi-prep protein A beads (Bio-Rad Labora- 
tories, Hercules,  CA)  at  0.5  mg/ml using dimethylpimelimidate as  de- 
scribed (Harlow and Lane, 1988). Rabbit antibodies to CP190 amino acids 
2299-2554  were prepared as described above. Random rabbit IgG was ob- 
tained from Jackson ImmunoResearch Laboratories, Inc.  (West Grove, 
PA). A total of 100 Id of beads were incubated for 1 h at 4°C with 3 ml of 
Drosophila embryo extract prepared as in (Kellogg and Alberts, 1992) ex- 
cept that only two volumes of buffer containing 100 mM KCI were used to 
re-suspend the embryos. The beads were then extensively washed with 50 
mM Hepes, pH 7.6, 1 M KC1, 1 mM Na  3 EGTA, 1 mM MgC12, 10% glyc- 
erol, 0.05%  NP-40,  plus  1:200  protease inhibitor stock  (Kellogg et al., 
1989). Cycled tubulin at 15 mg/ml in BRB80 (80 mM potassium Pipes, pH 
6.8, 1 mM MgC12, 1 mM Na  3 EGTA) was polymerized by the addition of 
an equal volume of BRB80, 20% dimethylsulfoxide, 2 mM GTP at 37°C. 
The microtubules were stabilized following polymerization by the addi- 
tion of taxol to 100 ILM. Microtubules (5  ILl) were diluted into 125 ILl of 
equilibration buffer (20 mM potassium Pipes, pH 6.8, 50 mM potassium 
acetate, 1 mM MgC12, 1 mM Na3 EGTA) plus 0.1% Tween 20 before incu- 
bation with 50  ILl of beads for 20 min at room temperature. The beads 
were centrifuged through 10 ml sucrose step gradients consisting of 5 ml of 
70%  sucrose and 5 ml of 30%  sucrose in equilibration buffer plus 0.1% 
Tween 20  using a  table top centrifuge (International Equipment Com- 
pany, Needham Heights, MA) at top speed for 10 rain. Proteins pelleted 
with beads were analyzed by SDS-polyacrylamide gel electrophoresis. 
Microtubule Cosedimentation Assays (Bacterially 
Expressed Fusion Proteins) 
To 30 Ixg of each fusion protein in FPLC buffer, we added 13 tLg of the T4 
bacteriophage gene 45 protein (Morris et al.,  1979) as a carrier. The vol- 
ume of each sample was brought up to 66 ILl with FPLC buffer, which was 
then exchanged for equilibration buffer using spin desalting columns. The 
fusion proteins were centrifuged at 100,000 rpm for 10 min in the TLA 100 
rotor (Beckman Instruments, Fullerton, CA). Cycled tubulin at 18.5 mg/ 
ml in BRB80  was used to prepare taxol stabilized microtubules as de- 
scribed above. Fusion protein (10 ILl) was mixed with 80 ixl of equilibra- 
tion buffer containing 200 ILg/ml gene 45 protein (as carrier) and either 10 
t-d of microtubules or 10 ILl of control buffer. The mixtures were layered 
over 100 ILl cushions of 80 mM potassium Pipes, pH 6.8, 1 mM MgC12, 1 
mM Na3 EGTA, 50% glycerol, and were then centrifuged at 100,000 rpm 
for 10 min in the TLA 100 ultracentrifuge. Supernatants and pellets were 
then analyzed by electrophoresis on 13.5% polyacrylamide gels. 
Microtubule Bundling Assays 
Cycled tubulin (8 ~l of 10 mg/ml) and rhodamine-labeled cycled tubulin (2 
ILl of 10 mg/ml) were added to 10 ILl of BRB80 plus 2 mM GTP. The tubu- 
lin was allowed to polymerize at 37°C for 20 min. Labeled microtubules 
were stabilized by the addition of 80 ILl of BRB80 plus 20 ixM taxol. Fu- 
sion protein (1 ILl of 0.5 mg/ml in 50 mM potassium phosphate, pH 8.0, 300 
mM KC1, 1 mM 2-mercaptoethanol) was mixed with 2 ILl of rhodamine- 
labeled microtubules. The mixture was incubated at room temperature for 
10 min and then diluted 1:25 into BRB80, 60% glycerol, 0.1% glutaralde- 
hyde, plus an oxygen scavenging system (50 ILg/ml catalase, 100 ~g/ml glu- 
cose oxidase, 12.5 mM glucose), and mounted for viewing under the fluo- 
rescence microscope. 
The tubulin used in the experiments described in this paper was puri- 
fied from bovine brain according to Mitchison et al.  (1984),  through the 
phosphocellulose chromatography  step.  As  judged  by  SDS-polyacryl- 
amide gel electrophoresis, it is free of detectable microtubule associated 
proteins (MAPs). 
Results 
Identification of Protein Domains Responsible for the 
Centrosomal and Nuclear Localizations of CP190 
After PCR was used to amplify six overlapping fragments 
of the CP190 cDNA, these fragments were cloned into the 
vector pQE9 to construct a series of fusion proteins (Fig. 
1), each with a  12-amino acid tag containing 6-histidine 
residues at its amino terminus. Each of the fusion proteins 
is denoted by its CP190 amino acid numbers; (Whitfield et 
al., 1995). These fusion proteins were soluble and could be 
purified under native conditions; however, fusion proteins 
including  amino  acids  1-166  were  insoluble  and  were 
Figure 1.  A  map of the 6XHis tagged fusion proteins used in in- 
jection experiments. Purified fusion proteins containing the indi- 
cated  sequences from  CP190  (amino  acid  numbers  are  shown) 
were  rhodamine-labeled  and  injected into  syncytial Drosophila 
embryos. The columns to the fight summarize the localization of 
each fusion protein,  as observed by time-lapse confocal micros- 
copy. In the inset, each of the purified fusion proteins has been 
analyzed  by  SDS-polyacrylamide  gel  electrophoresis  (13.5% 
polyacrylamide)  and  detected by staining with Coomassie blue. 
The size of markers in kilodaltons is indicated in the left margin. 
For  the injection experiments, the highest concentration  tested 
was often limited by the solubility of the fusion protein. The max- 
imum concentration injected was 4.6, 4.5, 5.6, 7.3, 13.6,  15.0, and 
3.0 mg/ml for each fusion protein, as listed from top to bottom in 
the figure: each protein showing positive localization gave consis- 
tent results at concentrations of 1.5-2.0 mg/ml and higher. 
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sion proteins  reveals  three  dif- 
ferent  localization  patterns. 
Confocal  micrographs  of  living 
embryos  co-injected  with 
rhodamine-labeled  fusion  pro- 
tein  and  fluorescein-labeled 
40,000-mol wt dextran. Each set 
of  micrographs  was  selected 
from a time-lapse series taken of 
a  portion of the  embryo's sur- 
face  during several  cell  cycles. 
The  localization  patterns  are 
classified according to the local- 
ization  of  the  fusion  proteins 
during  interphase  and  mitosis 
(interphase  localization/mitotic 
localization).  Shown  here  for 
each  fusion  protein  are  inter- 
phase (top) and metaphase (bot- 
tom)  of  the  same  cell  cycle. 
Rhodamine-labeled fusion pro- 
tein is  on  the  left  and  fluores- 
cein-labeled  dextran  is  on  the 
right. The 40,000-mol wt dextran 
was injected at concentrations of 
0.15-0.3  mg/ml; the fusion pro- 
teins were injected at a  concen- 
tration of 1.7  mg/ml.  Examples 
of the three localization patterns 
obtained are  shown:  (a)  Co-in- 
jection  of  rhodamine  labeled 
GST-167-321 and 40,000-mol wt 
fluorescein  dextran.  GST-167- 
321 has a nuclear/cytoplasmic lo- 
calization pattern; it is imported 
into nuclei as they reform in te- 
lophase and is completely local- 
ized  in  nuclei  by  interphase. 
Upon  nuclear envelope  break- 
down, the fusion protein imme- 
diately disperses  into  the  cyto- 
plasm.  Because  the  40,000-mol 
wt dextran is excluded from nu- 
clei  as  they  reform,  the  nuclei 
appear  as black holes against a 
cytoplasmic background of dext- 
ran.  Upon  nuclear  envelope 
breakdown,  the  dextran  imme- 
diately diffuses  into the  nuclei. 
(b)  266-608 is an example  of a 
centrosomal/centrosomal  pat- 
tern of localization; it is found at 
centrosomes  at  constant  levels 
throughout  the  cell  cycle.  (c) 
167-608  is an example of a  pro- 
tein that  cycles between nuclei 
and  centrosomes  giving  a  nu- 
clear/centrosomal  localization 
pattern.  This  protein  accumu- 
lates in nuclei during telophase 
and  remains  there  throughout 
interphase;  upon  nuclear enve- 
lope breakdown, it immediately 
begins  to  accumulate  at  cen- 
trosomes.  The  centrosomal  lo- 
calization  peaks  by  metaphase 
and remains relatively constant 
until the  subsequent telophase. 
Bars, 10 ~m. therefore not pursued. We purified the overlapping fusion 
proteins in Fig. 1 by Ni-NTA agarose affinity chromatog- 
raphy followed by passage over a FPLC Superose 12 sizing 
column. The sizing column step removed aggregated fu- 
sion protein and truncated products and was often essen- 
tial to get functional proteins. After fluorescent labeling of 
the  purified  fusion  proteins  with  N-hydroxysuccinimidyl 
rhodamine  at  low  stoichiometry,  we  injected  them  into 
Drosophila  embryos during or just prior to the late syncy- 
tial  nuclear  divisions  (cycles  10-14);  fluorescein-labeled 
40,000-mol wt dextran was co-injected to serve as a cell cy- 
cle marker (Kalpin et al., 1994). 
At early stages of Drosophila  development, the embryo 
is a syncytium, so injected protein can diffuse via the com- 
mon cytoplasm to the hundreds of nuclei present. By cycle 
10, the nuclei have migrated to form a uniform monolayer 
just beneath the cortex (Foe and Alberts, 1983), simplify- 
ing their visualization. We followed these nuclei and their 
associated centrosomes using fluorescent time-lapse con- 
focal microscopy. During interphase, the nuclei appear in 
the  fluorescein channel  as black holes that  exclude dex- 
tran. At prometaphase, when the nuclear envelope breaks 
down, dextran floods into the nucleus, thus allowing us to 
accurately assess the  cell cycle state  of the  injected  em- 
bryos (Fig. 2). 
Injection of each of the labeled fusion proteins resulted 
in either no localization or one of three localization patterns 
that we have designated nuclear/cytoplasmic, nuclear/cen- 
trosomal, and centrosomal/centrosomal, according to their 
locations during interphase and mitosis (interphase local- 
ization/mitotic localization). The first pattern, nuclear/cy- 
toplasmic, is exemplified by fusion protein  167-321  (Fig. 
1). This fusion protein is localized to the cytoplasm during 
mitosis, and is imported into reforming nuclei in telophase 
where it remains throughout interphase. Upon nuclear en- 
velope breakdown, fusion protein 167-321  disperses evenly 
throughout  the  cytoplasm where  it  remains  throughout 
mitosis. The localization of this portion of CP190 when in- 
jected as a GST fusion protein was identical to that of the 
smaller 6XHis fusion protein (see Fig. 2 a, GST-167-321). 
Injection of fusion protein 167-468  resulted in a nuclear/ 
centrosomal pattern of localization, labeling nuclei during 
interphase  and  showing  weak  centrosomal  localization 
during mitosis. Fusion protein 266-608 gave a centrosomal/ 
centrosomal pattern of localization (Fig. 2 b), strongly lo- 
calizing to centrosomes with equal  intensity during both 
interphase and mitosis. 
We constructed fusion protein 167-608  (Fig. 1) to see if 
we could enhance  the  centrosomal localization of fusion 
protein 167-468  while maintaining its nuclear/centrosomal 
pattern  of  localization.  This  protein  localized  to  nuclei 
during interphase and gave a robust centrosomal localiza- 
tion during mitosis, mimicking the localization pattern of 
the native protein (Fig. 2 c). 
Characterization of a Region of CP190 Responsible 
for Nuclear Localization 
Based on our injection data, the region responsible for the 
nuclear localization of our fusion proteins is located be- 
tween amino acids 167 and 321.  Closer examination of the 
amino acid sequence in this region identified  a  potential 
bipartite nuclear localization signal (NLS) between amino 
acids 237 and 255 (Fig. 3). A  bipartite NLS consists of two 
Figure 3.  Characterization of the region of CP190 responsible for 
nuclear localization.  Fusion proteins in the region of the nuclear 
localization  domain are diagrammed here. The top 4 fusion pro- 
teins were 6XHis tagged and were injected  at concentrations of 
4.6, 1.3, 3.1 and 2.7 mg/ml (in order from top to bottom); the bot- 
tom four were fusions of small pieces of CP190 with glutathione- 
S-transferase  and were injected  at concentrations  of 3.3, 1.5, 2.3, 
and 3.8 mg/ml (in order from top to bottom). Purified fusion pro- 
teins  were rhodamine-labeled and injected  into syncytial  Dro- 
sophila embryos. Nuclear localization  was scored by subsequent 
observation on an inverted fluorescence  microscope.  From this 
data, the region that we believe to be responsible  for nuclear lo- 
calization is found between amino acids 207 and 271. The basic 
residues are underlined.  A bipartite NLS is found between amino 
acids 237 and 255. 
Figure 4.  Characterization  of the domain(s) of CP190 responsi- 
ble for its centrosomal localization. The 6XHis tagged fusion pro- 
teins diagrammed were rhodamine-labeled and injected into syn- 
cytial Drosophila embryos. Centrosomal localization  was scored 
by fluorescence  confocal  microscopy.  Two non-overlapping fu- 
sion proteins, 309-427 and 428-608, localize to centrosomes, sug- 
gesting that the centrosomal localization  domain contains  multi- 
ple  independent  elements  which  together  cooperate  to  give 
robust centrosomal localization. 
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mately  10  amino  acids,  followed  by another  region  of 5 
amino acids, 3 of which are basic; in many cases, the spacer 
can  vary  considerably  in  length  (Dingwall  and  Laskey, 
1991).  The  potential  NLS  in  CP190  has  a  spacer  of  13 
amino acids. 
The fusion proteins  shown in Fig.  3  were  labeled  with 
rhodamine and injected into embryos to test whether this 
potential NLS is responsible for the nuclear localization of 
our CP190 fusion proteins. Fusion protein 207-608 gave a 
nuclear/centrosomal  localization pattern,  confirming that 
it contains sufficient sequences to target the fusion protein 
to nuclei during interphase. Fusion protein 240-608 also gave 
a  nuclear/centrosomal  localization  pattern,  even  though 
this construct deletes  the upstream  element  of the bipar- 
tite NLS (Fig. 3). The slightly smaller fusion protein 266- 
608, representing  an  additional  NH2-terminal  deletion  of 
26  amino  acids,  however,  fails  to  concentrate  in  the  nu- 
cleus. Thus, sequences essential for the nuclear localization 
of CP190 appear to lie between amino acids 240 and 266. 
Some protein fragments were also expressed  as fusions 
with  GST.  The  GST fusion with  amino  acids  240-321  of 
CP190 does  not localize to the nucleus.  How can we ex- 
plain  these  results?  One  possible  explanation  is  that  the 
complete bipartite NLS between amino acids 237 and 255 
of CP190 is normally required for the nuclear localization 
of our fusion proteins,  but,  in  the  case  of fusion protein 
240-608 fused to 6XHis, the amino terminus with its posi- 
tive charge can fill in for the missing upstream pair of basic 
amino acids. 
Characterization  of the Domain of CP190 Responsible 
for Centrosomal  Localization 
To determine if we could further delineate  the domain of 
CP190 required to obtain centrosomal localization, smaller 
fusion  proteins  were  constructed  (Fig.  4).  A  124-amino 
acid 6XHis  fusion protein  corresponding to  amino  acids 
385-508 of CP190 was able to localize well to centrosomes 
when fluorescently labeled and injected into embryos. As 
seen previously for the larger fusion protein 266-608, this 
fusion protein localized to centrosomes constitutively, with 
equal intensity throughout the cell cycle. Fusion proteins 
421-608  and  309-456  contain  NH2-  and  COOH-terminal 
deletions, respectively, of part of the 124-amino acid region 
of 385-508 (see Fig. 4). These protein fragments also local- 
ize to centrosomes, although the ratio of centrosomal stain- 
ing to background cytoplasmic staining is decreased (data 
not shown). Two nonoverlapping fusion proteins, 309-427 
and 428-608 were then constructed. Although both of these 
proteins  localize to centrosomes,  this  localization is com- 
paratively  weak  (data  not  shown).  There  is  no  obvious 
amino acid homology between these two independent re- 
gions of CP190. These results suggest that the centrosomal 
localization domain is complex, spanning at least the 124- 
amino acid region which allows robust centrosomal local- 
Figure 5.  Native and bacterially expressed CP190 bind microtu- 
bules.  (a) Protein A  beads coupled to random IgG, anti-CP190 
amino  acids  385-508  or  anti-CP190  amino  acids  705-789  were 
mixed with Drosophila embryo extract.  The beads were washed 
extensively with buffer containing 1 M KCI to remove any pro- 
teins associated with CP190 and were then mixed with taxol-sta- 
bilized  microtubules or control buffer before layering on 10 ml 
sucrose step gradients and pelleting in a table top clinical centri- 
fuge. Pelleted beads were boiled in sample buffer and released 
proteins were analyzed by SDS-polyacrylamide gel electrophore- 
sis  (10%  polyacrylamide).  (Top) Coomassie-stained  gel.  (Bot- 
tom) Western blot of the central portion of the gel with the anti- 
a-tubulin mouse monoclonal DMla. Western blotting was neces- 
sary because IgG heavy chain that leached off the beads runs at 
the  same  molecular weight as  tubulin.  (b)  The  bacterially ex- 
pressed  6XHis  fusion  with  CP190  amino  acids  167-1090  was 
tested for its ability  to cosediment with taxol stabilized microtu- 
bules. The supernatants and pellets from sedimentations done in 
the absence (left two lanes) or presence (right two lanes) of taxol- 
stabilized  microtubules were analyzed by SDS-polyacrylamide gel 
electrophoresis. 
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trosomal localization and microtubule bundling is shown for fu- 
sion proteins in the region of the centrosomal localization domain. 
The ability of a fusion protein to cosediment with microtubules was 
qualitatively assessed based on cosedimentation assays  done at 
two salt concentrations. Experiments were carried out in 20 mM 
K-Pipes, pH 6.8, 50 mM potassium acetate, 1 mM MgC12, 1 mM 
Na3EGTA and in the same buffer plus 50 mM NaC1. Bundling as- 
says were performed as described in the legend to Fig. 8. N/T in- 
dicates that the fusion protein was not tested in the assay. 
Figure 6.  Identification of the region of CP190 important for its 
microtubule binding.  (Top) Map of the fusion proteins spanning 
CP190 that were tested for their ability to cosediment with micro- 
tubules. (Bottom) The supernatants and pellets from sedimenta- 
tions done in the absence (left two lanes in each box) or presence 
(right  two lanes  in  each box)  of taxol-stabilized  microtubules. 
The samples were separated by electrophoresis on 13.5%  poly- 
acrylamide gels and stained with Coomassie blue. The large band 
in the right-most lane in each box is tubulin. Fusion proteins 167- 
468 and 309-608 pellet only in the presence of microtubules. Fu- 
sion proteins 504-789, 646-937, and 784-1090 remain in the super- 
natant with or without microtubules. 
ization.  No  significant  homology was  found  when  these 
124 amino acids (the amino acids between 385 and 508) were 
compared alone, or as a part of larger fragments, to known 
protein databases using the BLAST comparison tool (Ats- 
chul et al., 1990). The centrosomal localization domain does 
overlap  slightly  with  the  central  domain  of  CP190  pre- 
dicted to encode four zinc fingers (Whitfield  et al.,  1995), 
since the fusion protein with amino acids 385-508 contains 
one putative zinc finger. However, this zinc finger can not 
be required for centrosomal localization since the fragment 
309-456, which contains no zinc fingers, also gives good lo- 
calization to centrosomes. 
The Domain of CP190 Responsible for Its Centrosomal 
Localization Cannot Be Separated from a Region That 
Confers an Ability to Cosediment with Microtubules 
Since CP190 was originally identified by microtubule-affinity 
chromatography (Kellogg, et al.,  1989), we wanted to de- 
termine  if native  CP190  could  bind  directly  to  microtu- 
bules. To do this, we used protein A  beads coupled to anti- 
CP190  antibody  to  immunoprecipitate  the  endogenous 
protein from Drosophila embryo extracts. The beads were 
subsequently  washed  with  buffer  containing  1  M  potas- 
sium  chloride  to  remove  proteins  which  associate  with 
CP190. The beads were then mixed with microtubules and 
sedimented  at low speed through a  sucrose step gradient. 
Fig. 5 a  shows the results of such an experiment.  CP190 is 
cleanly immunoprecipitated  by both anti-CP190  antibod- 
ies  (Fig.  5  a, last four lanes)  but not with random rabbit 
IgG. Microtubules co-pellet with the CP190 bound beads 
but not with control beads coupled to random IgG. 
Additionally, we found that a bacterially expressed 6XHis 
fusion protein containing amino acids 167-1090 of CP190 
would cosediment with microtubules in vitro (Fig. 5 b); the 
stoichiometry of this binding at saturation was one CP190 
167-1090 monomer to between four and five tubulin dimers 
(data  not shown), suggesting that  CP190 binds  along the 
lengths of microtubules in vitro. We localized the region of 
CP190 responsible for microtubule binding by subjecting a 
series  of smaller  fusion  proteins  to  the  cosedimentation 
test  (Fig. 6).  Fusion proteins  167-468 and 309-608 cosedi- 
mented quantitatively with microtubules under our condi- 
tions, whereas  the more COOH-terminal fusion proteins, 
(504-789, 646-937,  and 784-1090),  remained  in the  super- 
natant both in the presence  and absence  of microtubules 
(Fig. 6). We next tested the fusion proteins that were used 
to narrow down the centrosomal localization domain (Fig. 4) 
in our cosedimentation assay. As shown in Fig. 7, we were 
unable  to separate  the  region important  for centrosomal 
localization from the microtubule binding region; in fact, it 
seems  that  the  ability  of a  fusion  protein  to  cosediment 
with microtubules closely parallels its ability to localize to 
centrosomes. 
We also tested some of these fusion proteins to see if they 
could bundle rhodamine-labeled microtubules. Fusion pro- 
teins 309-608, 309-427, and 385-508 caused microtubules to 
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tive, as bundles would still form in the presence of 500 mM 
KC1 (data  not shown).  Fusion  proteins  421-608  and 428- 
608, although able to cosediment with microtubules, were 
not able to bundle microtubules  in our assay. Fig. 7 sum- 
marizes  the centrosomal localization,  microtubule  binding 
and microtubule bundling data for fusion proteins derived 
from the region of the centrosomal localization domain. 
Microtubules Are Not Required for the Accumulation 
or Maintenance of CP190 or CP60 at Centrosomes 
Centrosomal proteins can be divided into two groups: those 
proteins  that  require  microtubules  for their  centrosomal 
localization and those capable of localizing to centrosomes 
independent  of microtubules.  The  first group is likely to 
include proteins that function to organize the spindle pole, 
as well as proteins that accumulate at the centrosome due 
to its role as a  hub for intracellular  trafficking. Examples 
of proteins in the first group include NCD (a minus end- 
directed microtubule motor protein) and NuMA a protein 
important for spindle pole integrity (also called centrophi- 
lin, SP-H, and SPN), both of which localize to spindle poles 
in a  microtubule-dependent  manner (Price and Pettijohn, 
1986; Kallajoki et al., 1991; Tousson et al., 1991; Endow et 
al., 1994). The group of proteins that localize to centrosomes 
independent of a nucleated microtubule array can be con- 
sidered components of a "core" centrosome, defined as the 
structure that remains when microtubules have been depo- 
lymerized.  Known components of "core" centrosomes in- 
clude ~/-tubulin and pericentrin (Stearns et al., 1991; Zheng 
et al., 1991; Doxsey et al., 1994). 
Since there was a  correlation between  the centrosomal 
localization of our fusion proteins and their ability to cosed- 
iment with microtubules in vitro, we predicted that the as- 
sociation of CP190 with microtubules might function to lo- 
calize  CP190  to  centrosomes  in  vivo.  Moreover,  not only 
does CP60 associate biochemically with CP190 (Kellogg and 
Alberts,  1992)  and  likewise  localize  to  nuclei  and  cen- 
trosomes in a cell cycle specific manner, but bacterially ex- 
pressed  CP60, like  CP190,  binds  directly to microtubules 
in vitro (Kellogg et al., 1995). Therefore, we wanted to de- 
termine  if either  CP60 or CP190 require  microtubules  to 
accumulate at centrosomes, rather than being components 
of "core" centrosomes. Previously, we have shown that there 
is no apparent difference in the amount of CP190 or CP60 
detected by immunofluorescence at centrosomes between 
control  mitotic  embryos  and  colchicine-treated  embryos 
arrested  in mitosis  (Raft et al.,  1993).  These experiments 
demonstrated that CP190 and CP60 remain at centrosomes 
when microtubules are depolymerized, suggesting that mi- 
crotubules are not required  to maintain their centrosomal 
Figure 8.  Assaying microtubule bundling. To assay MT bundling, 
2 txl of rhodamine-labeled microtubules was mixed with 1 txl of 
purified fusion protein and the mixture was incubated at room 
temperature for 10 min before dilution into fix (see Materials and 
Methods). (A) Buffer control microtubules are not bundled. (B) 
fusion protein 428-608 also cannot bundle microtubules. (C) Ad- 
dition of fusion protein 385-508 causes microtubules to form tight 
bundles (the apparent fraying of the ends of the bundles is mis- 
leading, being due to the bundles leaving the plane of focus). 
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bryos shows  that  CP190 and  CP60  make  the 
transition  from the  nucleus  to the  centrosome 
even  in  the  absence  of  microtubules.  6XHis 
tagged CP60  and 6XHis  tagged CP190  (amino 
acids  167-1090) were purified  and labeled with 
rhodamine. The purified fusion proteins were in- 
jected in 50 mM Hepes, 100 mM NaC1, 5 mM 
colchicine.  Immediately following  injection,  in- 
terphase embryos that had imported CP190 or 
CP60  into  their  nuclei  were  selected  and  fol- 
lowed  into mitosis:  Z-series were taken on the 
confocal  microscope during  interphase and the 
subsequent  colchicine  induced  arrest.  In  this 
way,  we  were able  to watch  CP190 and  CP60 
make the transition  from nuclear to centrosomal 
localization in the absence of microtubules in live 
embryos. Shown  here are projections of these 
Z-series done using the COMOS software that 
operates the confocal microscope (BioRad Lab- 
oratories). Bar, 10 ~m. 
localization. However, microtubules could nevertheless have 
a role in causing the movement of CP190 or CP60 to cen- 
trosomes. 
To test the effect of microtubule depolymerization on the 
ability of CP190 and CP60 to accumulate at centrosomes, we 
co-injected 5 mM colchicine and either purified rhodamine- 
labeled 6XHis CP60 (full length) or 6XHis CP190 (amino 
acids  167-1090).  The injected embryos were immediately 
screened to find interphase embryos that had imported the 
fluorescent CP190 or CP60 into their nuclei. The embryos 
were then followed using time-lapse confocal microscopy 
until they entered a colchicine-induced mitotic arrest (Fig. 
9). Control embryos were similarly injected and then fixed 
and stained for microtubules to insure that our treatment 
was  depolymerizing  microtubules  completely  (data  not 
shown).  We found that CP190  and  CP60 accumulated at 
centrosomes with normal kinetics in the absence of micro- 
tubules, suggesting that microtubule binding plays no role 
in localizing either CP190 or CP60 to centrosomes. 
Neither CP190 nor CP60 Bind along the Length of 
Microtubules  In Vivo 
Since  neither  CP60  nor  CP190  require  microtubules  for 
transport to centrosomes, we performed double-label im- 
munofluorescence to detect et-tubulin and either CP190 or 
CP60  in  the  same  embryo.  The  aim  was  to  determine 
whether these proteins localize along the lengths of micro- 
tubules  in  vivo,  as  previously  demonstrated  for  several 
MAPs  (Kreis and Vale,  1993).  Neither  CP190  nor CP60 
could be detected along the lengths of microtubules at any 
point during the cell cycle (Fig.  10).  Although  present in 
the region of the spindle during mitosis, CP190 and CP60 
exhibit a granular staining similar in character to their nu- 
clear staining during interphase. If there is an interaction 
between CP190 or CP60 and microtubules in the spindle, 
this interaction is not similar to that of conventional MAPs. 
Discussion 
This paper presents the beginnings of a molecular charac- 
terization of CP190. We have identified the regions of CP190 
important for its dynamic pattern of nuclear and centroso- 
real localization inside the cell, as well as for its ability to 
cosediment  with  microtubules  in  vitro.  These data,  com- 
bined with the results of in vivo experiments that test for a 
role  of microtubules  in  the  centrosomal  localization  of 
CP190 and CP60,  shed light on the mechanism by which 
these two proteins localize to centrosomes in vivo. 
When  a  set  of 6XHis fusion proteins  spanning  CP190 
were  bacterially  expressed,  purified,  rhodamine-labeled, 
and injected into Drosophila embryos, the injected proteins 
either did not localize or exhibited one of three localiza- 
tion patterns which we have designated nuclear/cytoplas- 
mic, nuclear/centrosomal and centrosomal/centrosomal (to 
represent localizations during interphase  and mitosis, re- 
spectively). A  fusion protein containing amino acids 167- 
608, ~40%  of full-length CP190, localizes to centrosomes 
during mitosis and to nuclei during interphase, in a  man- 
ner that closely mimics the localization pattern of the na- 
tive protein.  The  region  of CP190  between  amino  acids 
167  and 608 was further divided to identify independent 
domains responsible for centrosomal or nuclear localiza- 
tion. These results are summarized in Fig. 11. 
The  region  responsible  for the  nuclear  localization  of 
our  fusion  proteins  contains  a  bipartite  NLS  (Dingwall 
and Laskey, 1991) between amino acids 237 and 255, sug- 
gesting that the nuclear import of CP190 is signal depen- 
dent. We also note that CP190 contains a second potential 
bipartite NLS between amino acids 125  and  144,  in a  re- 
Oegema et al. The Cell Cycle~dependent  Localization  of CP190  1269 Figure 10.  CP60 and CP190 do not co-localize with microtubules in vivo. (a) Double label immunofluorescence of CP190 and et-tubulin in 
syncytial Drosophila embryos. (b) Double label immunofluorescence of CP60 and a-tubulin in syncytial Drosophila embryos. Neither 
CP190 nor CP60 are found along the lengths of microtubules at any stage of the cell cycle. During mitosis CP190 and CP60 appear to 
stain residual nuclear structures in the region of the spindle. Bars, 10 ixm. 
The Journal of Cell Biology, Volume 131, 1995  1270 gion of CP190 that we were not able to study due to its in- 
solubility when expressed in bacteria. This additional NLS 
could also contribute to the nuclear localization of the na- 
tive protein. 
A  fusion protein containing the 124 amino acids 385-508 
is sufficient for robust localization to centrosomes.  Frag- 
ments that localize to centrosomes that lack a NLS, such as 
266-608  (Fig. 3), remain at centrosomes at constant levels 
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Figure11. A Map summarizing the locations of the identified do- 
mains  of CP190. The  nuclear  localization  domain  is  between 
amino acids 207 and 271. The region of CP190 between amino ac- 
ids 385 and 508 is sufficient for both good centrosomal localiza- 
tion and cosedimentation with microtubules in vitro. The region 
of CP190 between amino acids 472 and 590 contains four putative 
zinc fingers- the arrows point to the center of each putative zinc 
finger. 
throughout the cell cycle. In contrast, fusion proteins that 
are only slightly longer, and which contain a NLS, such as 
240-608, mimic the localization pattern of the native pro- 
tein.  Thus addition  of the 26 amino acids containing  the 
NLS confers the ability to be released from centrosomes 
during interphase as well as the ability to localize to nuclei. 
This suggests that CP190 is effectively pulled away from 
centrosomes during interphase by its sequestration into in- 
tact nuclei. 
Weak centrosomal localization can be achieved by two 
adjacent, independent fragments of CP190, each contain- 
ing a  distinct portion of the 124-amino acid domain that 
produces strong centrosomal localization. There is no sig- 
nificant amino acid homology between the two indepen- 
dent fragments, suggesting the absence of a repeated motif 
for centrosomal binding. It nevertheless appears that sepa- 
rate parts of the localization domain can confer some cen- 
trosomal binding and, when put together, they act cooper- 
atively to give the strong centrosomal localization found in 
fragments containing the entire domain. (A caveat is that 
we cannot  distinguish  between  weak localization  due  to 
poor folding of our fusion proteins and weak localization 
due to lack of essential sequences.) 
When a Drosophila embryo extract is passed over a mi- 
crotubule  affinity column, CP190 interacts with microtu- 
bules (Kellogg et al., 1989).  This result, however, could re- 
flect binding of CP190 to other proteins that bind directly 
to microtubules. It is therefore interesting that both native 
CP190  and  a  bacterially expressed fusion  protein  corre- 
sponding to the COOH-terminal 85% of CP190 can bind 
directly to microtubules in vitro. We have narrowed down 
the microtubule binding domain of CP190 and find that it 
is inseparable from the region required for centrosomal lo- 
calization  (see Fig.  7).  The  microtubule binding  domain 
has no detectable homology to other known microtubule 
binding domains (Lewis et al., 1988; Himmler et al., 1989; 
Noble et al., 1989; Yang et al., 1989; Irminger-Finger et al., 
1990; Aizawa et al., 1991). 
Depolymerization of microtubules in vivo using colchi- 
cine does not noticeably affect the rate or extent of accu- 
mulation  of CP190  or  CP60  at  centrosomes,  suggesting 
that they are members of a very small set of characterized 
proteins that do not require microtubules to attain or main- 
tain their centrosomal localizations. Many other character- 
ized  centrosomal components such  as NuMA  and NCD 
require microtubules for their localization to spindle poles 
or microtubule asters. CP190 and CP60, on the other hand, 
seem to be cell cycle-dependent components of a  "core" 
centrosome, independent of the nucleated microtubule ar- 
ray.  Other  known  components  of core  centrosomes  in- 
clude ",/-tubulin and pericentrin (Steams et al., 1991; Zheng 
et al., 1991; Doxsey et al., 1994). 
This raises the important question  of the in vivo rele- 
vance of the in vitro binding of both CP190 and CP60 to 
microtubules. By immunofluorescence, there is no obvious 
colocalization of CP190 or CP60 along the lengths of mi- 
crotubules  in the spindle  or during  interphase  (Fig.  10). 
We can think of three possibilities to explain our data: (a) 
CP190  and  CP60  localize  to  the  centrosome  by mecha- 
nisms independent of MT binding, but function as micro- 
tubule binding proteins at the centrosome. (b) The binding 
of CP190 and CP60 to microtubules observed in vitro re- 
flects a related but different association that is important 
for the binding of these proteins to centrosomes. For ex- 
ample, CP190 and CP60 could bind to ",/-tubulin  at the cen- 
trosome (Raft et al., 1993).  (c) The binding of CP190 or 
CP60 to microtubules could be an in vitro artifact, medi- 
ated by positively charged regions on the surface of these 
proteins. 
The identification of the nuclear and centrosomal local- 
ization domains of CP190 is a first step towards probing its 
function; these domains can now be mutated and further 
analyzed.  In addition,  we can attempt to block the  cen- 
trosomal localization of native CP190 in Drosophila em- 
bryos by the injection of antibodies to the centrosomal lo- 
calization domain, or by the injection of short CP190 fusion 
proteins. (Some of the fusion proteins that bind centrosomes 
could have a dominant negative effect.) Finally, by trans- 
forming Drosophila with a full-length CP190 carrying point 
mutations designed to disrupt its nuclear localization se- 
quences,  we should  be able to retain this protein at the 
centrosome throughout the cell cycle. If CP190 is seques- 
tered in nuclei during interphase to keep it from interfer- 
ing with centrosome function, such a mutation should pro- 
duce a clear phenotype. 
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